New Leaf Venture Partners LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
⚲
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
New Leaf Venture Partners LLC
✚
CRD #163897
SEC #801-80793
CIK #0001631614
AUM 408.4 M (2026-03-30)
Employees 4 (50% Investors, 0% Brokers)
Fees
Minimum
Phone646-871-6420
Address156 Fifth Avenue
New York, NY 10010
Source [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn]
Total AUM ($M)
110088066044022002010201520212027
Sector Form 13F Holdings Value ($M)
Edgewise Therapeutics Inc 16.7
Arvinas Inc 13.5
Crinetics Pharmaceuticals Inc 5.9
UNUM Therapeutics Inc 3.6
Rallybio Corp 1.6
Alector Inc 1.0
Passage Bio Inc 0.7
 
 
 
 
Holdings by Sector ($M)
60048036024012002013201720212026
Type Form D Funds Date Sold AUM
VC NLV Co-Invest IV LP [2025-03-31] 16.7 M 16.8 M
Offered $16,660,000 · Filed 2024-12-31 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Not Applicable
VC NLV-II SPV-1 LP [2024-03-28] 90.8 M
VC NLV-II SPV-2 LP [2024-03-28] 9.0 M
Filed 2023-11-13 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Not Applicable
VC NLV Co-Invest III LLC 2022-03-30 9.0 M
VC NLV Co-Invest II LLC 2021-03-25 5.3 M
VC New Leaf Biopharma Opportunities II LP [2019-03-29] 120.7 M
Offered $200,000,000 · Filed 2018-04-16 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $200,000,000 · Duration One year or less · Revenue Not Applicable
VC New Leaf Ventures IV LP [2019-03-29] 94.4 M
Offered $275,000,000 · Filed 2018-04-16 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $275,000,000 · Duration One year or less · Finder's Fee $25,000 · Revenue Not Applicable
VC New Leaf Biopharma Opportunities I LP [2014-12-19] 10.0 M
Offered $200,000,000 · Filed 2014-12-04 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $200,000,000 · Duration One year or less · Revenue Not Applicable
VC New Leaf Ventures III LP [2014-12-19] 62.4 M
Offered $375,000,000 · Filed 2014-12-03 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $375,000,000 · Duration One year or less · Revenue Not Applicable
VC NLV Partners Co-Invest I LLC 2014-12-19 8.0 M
View All
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 9 408.4
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 9 408.4
By Discretionary
Discretionary 9 408.4
Non-Discretionary 0 0.0
Total 9 408.4
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 408.4
Total 9 408.4
Limited Partners2011 - 2026
State of Michigan Retirement System
Form D Directors Role # Filings # Firms 2011 - 2026
Vijay Lathi Executive Officer 34 2
Jeani Delagardelle Executive Officer 32 2
Liam Ratcliffe Executive Officer 25 2
Ronald Hunt Executive Officer 25 2
Ron Hunt Executive Officer 20 2
Philippe Chambon Executive Officer 13 2
Isaac Manke Executive Officer 8 2
Nlv SPV GP LLC Executive Officer 3 2
New Leaf Venture Management III LLC Director 3 2
Craig Slutzkin Executive Officer 3 2
View All
EDGAR Form CIK 2011 - 2026
13F-HR [0001631614]
3 [0001631614]
4 [0001631614]
Firm Profile (Form ADV)
ServesInstitutional
Fund TypesPrivate Equity
Form 3/4/5 Subject 2011 - 2026
PDS Biotechnology Corp
Ratcliffe Liam
New Leaf Venture Partners LLC
New Leaf Venture Management III LLC
New Leaf Venture Associates III LP
New Leaf Ventures III LP
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
PDS Biotechnology Corp EDGE
Stock Option (right to purchase) · derivative
2016-06-21 Grant 30,000 $0.00
Comparable Firms State AUM
Auldbrass Partners LP
✚
NY 412.9 M
Auxo Investment Partners LLC
✚
MI 412.0 M
Vortus Investment Advisors LLC
✚
TX 411.7 M
Peloton Equity LLC
✚
CT 409.5 M
Greenridge Equity Partners LLC
✚
TX 408.8 M
Bridge Growth Partners LLC
✚
NY 407.0 M
Generation Partners Management LLC
✚
401.6 M
ROG IX LLC
✚
TX 401.0 M
Palm Peak Capital LLC
✚
FL 400.8 M
ValueQuest Advisers LLC
✚
NY 400.8 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com